Bupropion treatment of attention-deficit hyperactivity disorder in adults
- 1 August 1990
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 147 (8), 1018-1020
- https://doi.org/10.1176/ajp.147.8.1018
Abstract
The authors treated 19 adults with attention-deficit hyperactivity disorder with an open trial of bupropion. These patients had received maintenance stimulant medication or monoamine oxidase inhibitors for an average of 3.7 years. Fouteen of the patients experienced moderate to marked benefit from bupropion; ten of these patients chose to continue bupropion rather than their former medication. These results suggest that bupropion may be an alternative to stimulants in treating some adults with attention-deficit hyperactivity disorder.This publication has 11 references indexed in Scilit:
- An open trial of L-tyrosine in the treatment of attention deficit disorder, residual typeAmerican Journal of Psychiatry, 1987
- A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adultsAmerican Journal of Psychiatry, 1985
- Cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid in adults with attention deficit disorder, residual typePsychiatry Research, 1984
- An open trial of pargyline in the treatment of attention deficit disorder, residual typePsychiatry Research, 1983
- REVIEW OF PLACEBO-CONTROLLED TRIALS WITH BUPROPION1983
- BUPROPION AND AMITRIPTYLINE IN THE TREATMENT OF DEPRESSED-PATIENTS1983
- Attention Deficit Disorder ('Minimal Brain Dysfunction') in AdultsArchives of General Psychiatry, 1981
- BEHAVIORAL AND BIOCHEMICAL EFFECTS OF THE ANTI-DEPRESSANT BUPROPION (WELLBUTRIN) - EVIDENCE FOR SELECTIVE BLOCKADE OF DOPAMINE UPTAKE INVIVO1980
- Diagnosis and Treatment of Minimal Brain Dysfunction in AdultsArchives of General Psychiatry, 1976
- THE MINIMAL BRAIN DYSFUNCTION SYNDROME IN CHILDRENJournal of Nervous & Mental Disease, 1972